Summary

• Page properties (1 modified, 0 added, 0 removed)

Details

Page properties

Content

...	...	@@ -2,7 +2,7 @@
2	2	{{toc/}}
3	3	{{/box}}
4	4
5		-= Company overview =
	5	+= Company Overview =
6	6
7	7	Since 1910, Abbott has been dedicated to helping people in India live healthier lives through a diverse range of science-based nutritional products, diagnostic tools, branded generic pharmaceuticals, and diabetes and vascular devices.{{footnote}}https://www.abbott.co.in/about-abbott/abbott-india-limited.html{{/footnote}}
8	8
...	...	@@ -16,6 +16,8 @@
16	16
17	17	Abbott in India develops and distributes over 600 products for healthcare professionals that promote health and well-being for Indians in all stages of life.{{footnote}}https://www.abbott.in/products/business-areas.pharmaceuticals-abbott-india-limited.html{{/footnote}}
18	18
	19	+{{putFootnotes/}}
	20	+
19	19	= Industry Overview =
20	20
21	21	The healthcare environment has been dynamic and, at times, volatile. As per IQVIA, a leading global provider of information and research services in the medical sector, Indian Pharmaceutical Market (IPM) is estimated at ` 149,900 Crore in 2020, its growth up by 2% from 2019. Acute therapies dominate IPM with 64% of the total sales; however, the chronic segment shows faster growth of 10.9% in comparison to 7.9% for acute therapies (3 year CAGR). The domestic pharmaceutical market is highly fragmented with the top 10 companies making up 43% of the share, and the top 150 companies accounting for 96% of share. Local players enjoy a dominant position, occupying 4 of the top 5 positions.{{footnote}}https://dam.abbott.com/en-ind/pdf/financials/2019-20-Annual-Report.pdf{{/footnote}}